Prostate Cancer Outcomes

Roswell Park is a leader in the field of prostate cancer active surveillance, with among the largest number of patients being managed with active surveillance in the region and nationally. Dr. Mohler explains.

Active surveillance provides an alternative management option for low-risk prostate cancer patients, which allows patients to delay or avoid altogether the morbidity of treatment. The goal is to detect disease progression at its earliest point in order to initiate treatment without missing the window for cure.

Increasing evidence supports the safety of this approach, and the National Comprehensive Cancer Network now recommends active surveillance as the first option for many men with low-risk prostate cancer.

Dr. Mohler explains the benefits of active surveillance and why Roswell Park is the best choice for prostate cancer treatment. 

Five-Year Survival, Prostate Cancer, Stages I, II, III & IV
Cases Diagnosed (2004-2010)

 
    0 1 2 3 4 5
(n=54) Roswell Park stage I 100% 100% 100% 100% 100% 100%
(n=1,291) Roswell Park stage II 100% 100% 100% 100% 100% 100%
(n=280) Roswell Park stage III 100% 100% 100% 100% 100% 100%
(n=163) Roswell Park stage IV 100% 91% 87% 75% 75% 75%
  SEER stage I 100% 99.50% 99.50% 99.50% 97.90% 95.80%
  SEER stage II 100% 100% 100% 100% 100% 100%
  SEER stage III 100% 100% 100% 100% 100% 100%
  SEER stage IV 100% 81.50% 66.70% 57% 50.10% 45.60%

American Joint Commission on Cancer (AJCC) Stage I-IV Prostate Cancer

Data source:
Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) SEER*Stat Database: Incidence - SEER 18 Regs Research Data + Hurricane Katrina Impacted Louisiana Cases, Nov 2013 Sub (1973-2011 varying) - Linked To County Attributes - Total U.S., 1969-2012 Counties, National Cancer Institute, DCCPS, Surveillance Research Program, Surveillance Systems Branch, released April 2014 (updated 5/7/2014), based on the November 2013 submission.